You have searched for "US drug company"
Showing 1-10 of 108
BOSTON (Reuters) - Virtually all U.S. doctors take freebies from drug companies, and a third take money for lecturing, signing patients up for trials or going to meetings, according to a survey published on Wednesday.
PARIS - One person has been left brain dead and five others have been hospitalised after taking part in a clinical trial in France of an experimental drug made by Portuguese drug company Bial, French Health Minister Marisol Touraine said on Friday.
NEW YORK (Reuters) - The U.S. Bureau of Prisons said on Friday it was investigating former drug company executive Martin Shkreli's conduct in prison after the Wall Street Journal reported he was still helping run his old company using a contraband cellphone.
NEW YORK (Reuters) - Martin Shkreli, the former drug company executive who made headlines by jacking up the price of a lifesaving drug before he was found guilty of defrauding investors, was sentenced to 7 years and a $75,000 fine on Friday.
NEW YORK (Reuters) - Former drug company executive Martin Shkreli may have to give up a Picasso and a one-of-a-kind Wu-Tang Clan album, after a U.S. judge on Monday ordered him to forfeit $7.36 million(5.31 million pounds) following his conviction of defrauding investors.
NEW YORK (Reuters) - Martin Shkreli, the pharmaceutical entrepreneur vilified as the "pharma bro" for raising the price of a life-saving drug by 5,000 percent, will go on trial on Monday for what U.S. prosecutors called a Ponzi-like scheme at his former hedge fund and a drug company he once ran.
NEW YORK (Reuters) - A New York lawyer was sentenced to 18 months prison on Friday for helping Martin Shkreli, currently serving a seven year prison sentence after being convicted of related charges, defraud a drug company that Shkreli had founded.
NEW YORK (Reuters) - U.S. prosecutors on Tuesday said former drug company executive Martin Shkreli should spend at least 15 years in prison after being convicted of fraud, saying his lack of remorse and respect for the law justified a long time behind bars.
(Reuters) - A federal judge on Friday refused to overturn former drug company executive Martin Shkreli's conviction of scheming to manipulate his company's stock price.